Download
to read the full article text
References
- 1.Pearce JM. Bromide, the first effective antiepileptic agent. J Neurol Neurosurg Psychiatry 2002;72: 412.CrossRefPubMedGoogle Scholar
- 2.Brodie MJ, Kwan P. Staged approach to epilepsy management. Neurology 2002;58(8 Suppl 5): S2-S8.PubMedGoogle Scholar
- 3.Loring DW, Marino S, Meador KJ. Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol Rev 2007;17: 413–425.CrossRefPubMedGoogle Scholar
- 4.Löscher W, Schmidt D. New horizons in the development of antiepileptic drugs. Epilepsy Res 2002;50: 3–16.CrossRefPubMedGoogle Scholar
- 5.Löscher W, Schmidt D. New horizons in the development of antiepileptic drugs: the search for new targets. Epilepsy Res 2004;60: 77–159.CrossRefPubMedGoogle Scholar
- 6.Löscher W, Schmidt D. New Horizons in the development of antiepileptic drugs: innovative strategies. Epilepsy Res 2006;69: 183–272.CrossRefPubMedGoogle Scholar
- 7.Dichter MA. Innovative clinical trial designs for future antiepileptic drugs. Epilepsia 2007;48(Suppl 1): 26–30.CrossRefPubMedGoogle Scholar
- 8.Rosenow J, Das K, Rovit RL, Couldwell WT. Irving S. Cooper and his role in intracranial stimulation for movement disorders and epilepsy. Stereotact Funct Neurosurg 2002;78: 95–112.CrossRefPubMedGoogle Scholar
- 9.Löscher W, Gemert M, Heinemann U. Cell and gene therapies in epilepsy—promising avenues or blind alleys? Trends Neurosci 2008;31: 62–73.CrossRefPubMedGoogle Scholar
Copyright information
© The American Society for Experimental NeuroTherapeutics, Inc. 2009